Alburx Related Published Studies
Well-designed clinical trials related to Alburx (Albumin Human)
Glycated albumin predicts the effect of dual and single antiplatelet therapy on
recurrent stroke. [2015]
Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation
end-products, and blood pressure in diabetic nephropathy. [2013]
High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a
randomised, double-blind, phase 3, placebo-controlled trial. [2013]
Albumin resuscitation for traumatic brain injury: is intracranial hypertension
the cause of increased mortality? [2013]
Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study. [2011.07]
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT). [2011.06]
The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. [2011.06]
Co-administration of albumin-furosemide in patients with the nephrotic syndrome. [2011.05]
Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients with type 2 diabetes and Microalbuminuria (IRMA 2) substudy. [2011.05]
Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. [2011.05]
Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy. [2011.05]
Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy. [2011.04]
Urinary albumin excretion during angiotensin II receptor blockade: comparison of combination treatment with a diuretic or a calcium-channel blocker. [2011.04]
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. [2011.03.14]
The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. [2011.02]
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial. [2011.02]
Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria. [2011.02]
The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. [2011.01]
Effect of chronic regular exercise on serum ischemia-modified albumin levels and oxidative stress in type 2 diabetes mellitus. [2011]
Metabolic effects of albumin therapy in acute lung injury measured by proton
nuclear magnetic resonance spectroscopy of plasma: a pilot study. [2011]
The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. [2011]
Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation
in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients
with type 2 diabetes and Microalbuminuria (IRMA 2) substudy. [2011]
Office and ambulatory pulse pressure--association with clinical characteristics
and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes
(ROADMAP study). [2011]
Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. [2010.08]
Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric effects of an aldosterone blocker in hypertensive patients with albuminuria. [2010.06]
Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. [2010.05.27]
99m Tc-albumin nanocolloid joint scintigraphy in rheumatoid arthritis patients who are in clinical remission - is remission real ? [2010.05]
Platelet-rich fibrin versus albumin in surgical wound repair: a randomized trial with paired design. [2010.05]
Lipoprotein profile, plasma ischemia modified albumin and LDL density change in the course of postprandial lipemia. Insights from the LIPGENE study. [2010.04.19]
[Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid mobilisation in Alzheimer's disease] [2010.03.16]
Dual blockade of the renin-angiotensin-aldosterone system is safe and effective in reducing albuminuria in Asian type 2 diabetic patients with nephropathy. [2010.02]
Ischemia-modified albumin reduction after coronary bypass surgery is associated with the cardioprotective efficacy of cold-blood cardioplegia enriched with N-acetylcysteine: a preliminary study. [2010]
Anti-glycation and anti-albuminuric effects of GLY-230 in human diabetes. [2010]
Human albumin for intradialytic hypotension in haemodialysis patients. [2010]
[Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid
mobilisation in Alzheimer's disease]. [Article in Spanish] [2010]
Serum albumin concentration: a predictive factor of infliximab pharmacokinetics
and clinical response in patients with ulcerative colitis. [2010]
Effects of saline or albumin resuscitation on standard coagulation tests. [2009.12]
Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. [2009.12]
Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. [2009.11]
Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. [2009.09]
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. [2009.07.07]
Albumin versus normal saline for dehydrated term infants with metabolic acidosis due to acute diarrhea. [2009.06]
Effect of Albumin Administration Prior to Exchange Transfusion in Term Neonates with Hyperbilirubinemia A Randomized Controlled Trial. [2009.05.20]
Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial. [2009.05]
A breakfast with alpha-lactalbumin, gelatin, or gelatin + TRP lowers energy intake at lunch compared with a breakfast with casein, soy, whey, or whey-GMP. [2009.04]
The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. [2009.04]
A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates. [2009.04]
Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. [2009.04]
Effect of megestrol acetate on serum albumin level in malnourished dialysis patients. [2009.03]
Avosentan reduces albumin excretion in diabetics with macroalbuminuria. [2009.03]
A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. [2009.02]
Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. [2009.02]
High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. [2009.02]
The natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study. [2009.01]
Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial. [2009]
Well-designed clinical trials possibly related to Alburx (Albumin Human)
Recombinant tissue-type plasminogen activator plus eptifibatide versus
recombinant tissue-type plasminogen activator alone in acute ischemic stroke:
propensity score-matched post hoc analysis. [2015]
Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a
randomised, double-blind, placebo-controlled trial. [2015]
Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in
maintenance hemodialysis patients. [2015]
Risk factors for postoperative CSF leakage after elective craniotomy and the
efficacy of fleece-bound tissue sealing against dural suturing alone: a
randomized controlled trial. [2014]
Objective approach for fending off the sublingual immunotherapy placebo effect in
subjects with pollenosis: double-blinded, placebo-controlled trial. [2014]
Clinical and preclinical characterization of the histamine H(4) receptor
antagonist JNJ-39758979. [2014]
Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin
resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver
disease patients. [2014]
Patient phenotypes associated with outcomes after aneurysmal subarachnoid
hemorrhage: a principal component analysis. [2014]
Potential vascular mechanisms of ramipril induced increases in walking ability in
patients with intermittent claudication. [2014]
Hydroxyethyl starch in sepsis. [2014]
Efficacy and safety of ETC-1002, a novel investigational low-density
lipoprotein-cholesterol-lowering therapy for the treatment of patients with
hypercholesterolemia and type 2 diabetes mellitus. [2014]
Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis:
study protocol for a randomized controlled trial. [2014]
Chuanhu anti-gout mixture versus colchicine for acute gouty arthritis: a
randomized, double-blind, double-dummy, non-inferiority trial. [2014]
Spironolactone to prevent cardiovascular events in early-stage chronic kidney
disease (STOP-CKD): study protocol for a randomized controlled pilot trial. [2014]
Effects of turmeric on uremic pruritus in end stage renal disease patients: a
double-blind randomized clinical trial. [2014]
Elevation in multiple serum inflammatory biomarkers predicts survival of
pancreatic cancer patients with inoperable disease. [2014]
Hydroxyethyl starch in sepsis. [2014]
The effect of prolonged systemic doxycycline therapy on serum tissue degrading
proteinases in coronary bypass patients: a randomized, double-masked,
placebo-controlled clinical trial. [2014]
Poor vitamin C status is associated with increased depression symptoms following
acute illness in older people. [2014]
Baseline characteristics in the Bardoxolone methyl EvAluation in patients with
Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal
eveNts (BEACON) trial. [2013]
New harmonic scalpel versus conventional hemostasis in right colon surgery: a
prospective randomized controlled clinical trial. [2013]
A phase II randomized vehicle-controlled trial of intradermal allogeneic
fibroblasts for recessive dystrophic epidermolysis bullosa. [2013]
Phase I, randomized, double-blind, placebo-controlled, multiple intravenous,
dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus. [2013]
Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and
vascular remodeling parameters in moderately hypercholesterolemic Italian
subjects. [2013]
Safety, pharmacokinetic, immunogenicity, and pharmacodynamic responses in healthy
volunteers following a single intravenous injection of purified staphylococcal
protein A. [2013]
Randomized clinical trial of arginine-supplemented enteral nutrition versus
standard enteral nutrition in patients undergoing gastric cancer surgery. [2013]
The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic
nephropathy: study protocol for a randomized, double-blind and placebo-controlled
clinical trial. [2013]
Resolution of Clostridium difficile-associated diarrhea in patients with cancer
treated with fidaxomicin or vancomycin. [2013]
The effects of ezetimibe/simvastatin versus simvastatin monotherapy on platelet
and inflammatory biomarkers in patients with metabolic syndrome. [2013]
Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver
cirrhosis: a double-blind randomized controlled trial. [2013]
Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive
pulmonary disease: a randomised clinical trial. [2013]
The effectiveness of fermented turmeric powder in subjects with elevated alanine
transaminase levels: a randomised controlled study. [2013]
Exposure-response relationship of tocilizumab, an anti-IL-6 receptor monoclonal
antibody, in a large population of patients with rheumatoid arthritis. [2013]
Clinical benefits of methylprednisolone in off-pump coronary artery bypass
surgery. [2013]
A randomized clinical trial to evaluate the effect of granulocyte-macrophage
colony-stimulating factor (GM-CSF) in embryo culture medium for in vitro
fertilization. [2013]
Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein
serum levels in patients with diabetic retinopathy. [2013]
Randomized controlled trial of vitamin D supplement on endothelial function in
patients with type 2 diabetes. [2013]
Oral resveratrol and calcium fructoborate supplementation in subjects with stable
angina pectoris: effects on lipid profiles, inflammation markers, and quality of
life. [2013]
Hepatic safety of injectable extended-release naltrexone in patients with chronic
hepatitis C and HIV infection. [2012]
Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation
in Asian patients with atherosclerosis. [2012]
STAR VaS--Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized
placebo-controlled trial evaluating perioperative atorvastatin therapy in
noncardiac surgery. [2012]
A randomized, double blind, placebo and active comparator controlled pilot study
of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical
origin. [2012]
Efficacy of a high-dose in addition to daily low-dose vitamin A in children
suffering from severe acute malnutrition with other illnesses. [2012]
The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial. [2012]
What is the best method of proteinuria measurement in clinical trials of
endothelin receptor antagonists? [2012]
Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan,
in patients with diabetes and chronic kidney disease (CKD). [2012]
|
